Skip to content

Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)

Etude de l'adhérence et Des Effets Des Ateliers équilibre Siel Bleu Sur la Marche, la Cognition, l'Autonomie et l'indépendance Des Sujets Atteints d'Une Maladie d'Alzheimer, et Sur le Fardeau de l'Aidant Principal

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01314638
Acronym
SIELBLEU
Enrollment
100
Registered
2011-03-14
Start date
2010-05-31
Completion date
2011-06-30
Last updated
2011-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Gait Apraxia, Impaired Cognition

Brief summary

The purpose of this study is to measure the adherence to Siel bleu balance exercises in patients with Alzheimer's disease, while taking into account the disease stages.

Detailed description

The practice of physical activity, more specifically postural balance exercises, is an intervention that improves gait performance in the elderly. Among patients with Alzheimer's disease, it seems that physical exercice also improves cognitive performance, reduces the loss of autonomy and independence in activities of daily living. All these effects may reduce the caregiver burden. Despite several initiatives in France, no study has been carried out to test the adherence to postural balance exercises and to examine the benefits on older AD patients and their caregiver. The main objective of this study is to measure the adherence to Siel bleu balance exercises in patients with Alzheimer's disease, while taking into account the disease stages.

Interventions

OTHERWorkshop balances

one workshop per week for 20 weeks. Evaluation before and after.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of Alzheimer's disease (AD) (DSM-IV/NINCDS-ADRDA criteria) * Age ≥ 65 years old * Mild AD (Mini-Mental State Examination score between 21 and 25), moderate AD (Mini-Mental State Examination score between 10 and 20) and severe AD (Mini-Mental State Examination score between 3 and 9) * Able to walk without any aid on 15 meters. * Near visual acuity ≥ 2 * Absence of severe depression (score of the 15-item Geriatric Depression Scale ≤ 10) * Written consent form to participate in the study (or trustworthy person or legal representative for severe AD) * Being affiliated to a social security regime

Exclusion criteria

* Musculoskeletal disorders not related to Alzheimer's disease * Near visual acuity \< 2 * History of cerebrovascular accident or other cerebro-spinal pathology * Poor workmanship of the written or oral French language * Refusal to be informed on possible hanging bare anomaly during study * Score of Mini-Mental State Examination \< 3 * Presence of severe depression (score of the 15-item Geriatric Depression scale \> 10) * Use of walking aid * Subject suffering from pre-existing impellent disturbances * Refusal to participate (or trustworthy person or legal representative)

Design outcomes

Primary

MeasureTime frame
Adherence to Siel Bleu balance exercicesbaseline

Countries

France

Contacts

Primary ContactCédric ANNWEILER, MD
ceannweiler@chu-angers.fr(+33) 241354550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026